NDC 50242-070 – Gazyva
Obinutuzumab 1000 mg/40mL · Injection, Solution, Concentrate · Intravenous
Product NDC50242-070
Product details
- Brand name
- Gazyva
- Generic name
- Obinutuzumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA125486
- Marketed since
- November 1, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- CD20-directed Cytolytic Antibody
Active ingredients
- Obinutuzumab 1000 mg/40mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50242-070-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-01) / 40 mL in 1 VIAL, SINGLE-USE | Nov 1, 2013 |
| 50242-070-86 sample | 1 VIAL, SINGLE-USE in 1 CARTON (50242-070-86) / 40 mL in 1 VIAL, SINGLE-USE | Nov 4, 2013 |